Prevalence and prognostic impact of subclinical venous congestion in patients hospitalized for acute heart failure
Sara Lozano-Jiménez(Centro de Investigación en Red en Enfermedades Cardiovasculares), Mercedes Rivas‐Lasarte(Universitat Autònoma de Barcelona), Jesús Álvarez‐García(Instituto de Salud Carlos III), Marta Cobo Marcos(Hospital Universitario Puerta de Hierro Majadahonda), Alba Martín Centellas(Hospital Universitario Puerta de Hierro Majadahonda), Francisco José Hernández-Pérez(Marqués de Valdecilla University Hospital), Belén García Magallón(Hospital Universitario de Móstoles), Marta Jiménez-Blanco Bravo(Instituto de Salud Carlos III), Cristina Mitroi(Hospital Universitario Puerta de Hierro Majadahonda), Manuel Gómez‐Bueno(Hospital Universitario Puerta de Hierro Majadahonda), Daniel de Castro(Ontario Institute for Cancer Research), Javier Segovia Cubero(Instituto de Salud Carlos III), José Luis Zamorano Gómez(Instituto de Salud Carlos III), Cristina García Sebastián(Hospital Universitario Ramón y Cajal), Paula Vela Martín(Hospital Universitario Puerta de Hierro Majadahonda), Susana del Prado Díaz(Instituto de Salud Carlos III)
Cited by 7
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
|European Heart Journal|2015|1.1k
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
|European Heart Journal|2017|373
COVID-19 in transplant recipients: The Spanish experience
|American Journal of Transplantation|2020|200
Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients for Primary Prevention
|Circulation Arrhythmia and Electrophysiology|2011|152